pirfenidone has been researched along with sildenafil citrate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajwah, S; Higginson, IJ; Koffman, J; Patel, AS; Peacock, JL; Riley, J; Ross, JR; Wells, AU | 1 |
| Behr, J; Bonella, F; Costabel, U; Geißler, K; Günther, A; Koschel, D; Kreuter, M; Müller-Quernheim, J; Prasse, A; Schönfeld, N; Sitter, H | 1 |
| Behr, J; Bengus, M; Gilberg, F; Harari, S; Kirchgaessler, KU; Nathan, SD; Wells, AU; Wuyts, W | 1 |
| Antoniou, K; Behr, J; Bengus, M; Bouros, DE; Gilberg, F; Guiot, J; Harari, S; Kirchgaessler, KU; Kramer, MR; Mogulkoc Bishop, N; Nathan, SD; Perjesi, A; Wells, AU; Wuyts, WA | 1 |
| Kang, J; Song, JW | 1 |
| Agredano-Jiménez, R; Alvarez-Villaseñor, AS; Barbosa-Camacho, FJ; Brancaccio-Pérez, IV; Chejfec-Ciociano, JM; Cortés-Flores, AO; Flores-Becerril, P; Fuentes-Orozco, C; González-Ojeda, A; Guzmán-Barba, JA; Guzmán-Ramírez, BG; Ibarrola-Peña, JC; Mares-País, R; Reyes-Elizalde, EA | 1 |
1 review(s) available for pirfenidone and sildenafil citrate
| Article | Year |
|---|---|
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cough; Dyspnea; Exercise Test; Fibrosis; Glucocorticoids; Heroin; Humans; Immunologic Factors; Lung; Lung Diseases, Interstitial; Narcotics; Oxygen Inhalation Therapy; Piperazines; Prednisolone; Purines; Pyridones; Quality of Life; Sildenafil Citrate; Sulfones; Thalidomide; Tubulin Modulators | 2013 |
3 trial(s) available for pirfenidone and sildenafil citrate
| Article | Year |
|---|---|
Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials, Phase II as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Multicenter Studies as Topic; Pyridones; Randomized Controlled Trials as Topic; Research Design; Sildenafil Citrate; Vasodilator Agents | 2018 |
Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial.
Topics: Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Idiopathic Pulmonary Fibrosis; Male; Pyridones; Sildenafil Citrate | 2021 |
Effect of sildenafil added to antifibrotic treatment in idiopathic pulmonary fibrosis.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Drug Therapy, Combination; Female; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung; Male; Middle Aged; Propensity Score; Pyridones; Sildenafil Citrate; Treatment Outcome; Vital Capacity | 2021 |
2 other study(ies) available for pirfenidone and sildenafil citrate
| Article | Year |
|---|---|
German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Antacids; Bosentan; Clinical Trials as Topic; Evidence-Based Medicine; Female; Gastroesophageal Reflux; Guideline Adherence; Humans; Idiopathic Pulmonary Fibrosis; Imatinib Mesylate; Indoles; Male; Middle Aged; Phenylpropionates; Pyridazines; Pyridones; Pyrimidines; Sildenafil Citrate; Sulfonamides | 2018 |
Effects of Oral Zafirlukast, Sildenafil, or Pirfenidone on the Formation of Postsurgical Intra-Abdominal Adhesions in an Experimental Rat Model.
Topics: Animals; Humans; Indoles; Male; Phenylcarbamates; Pyridones; Rats; Rats, Wistar; Sildenafil Citrate; Sulfonamides; Surgical Mesh; Tissue Adhesions | 2022 |